Faruqi & Faruqi Alerts DENTSPLY SIRONA Investors About Class Action Lawsuit

Faruqi & Faruqi, LLP highlights a critical class action lawsuit against DENTSPLY SIRONA Inc. (NASDAQ: XRAY) and reminds investors of an important lead plaintiff deadline set for January 27, 2025. Investors who experienced financial losses exceeding $75,000 during the specified period are encouraged to reach out for more information.

If you suffered losses from DENTSPLY between February 28, 2022, and November 6, 2024, and wish to explore your legal rights regarding the lawsuit, please contact Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

New York-based Faruqi & Faruqi, LLP has established itself as a prominent national securities law firm, dedicated to protecting investors' rights. The firm has a history of recovering over hundreds of millions of dollars for clients since its founding in 1995.

The class action lawsuit accuses DENTSPLY and its executives of breaching federal securities laws through various misleading claims and omissions, including that:

• Dentsply focused on low-income individuals lacking proper oral hygiene education and access to dental care, with many patients signing up for Byte despite underlying dental problems that disqualified them for treatment.
• Sales commissions incentivized employees to sell to unsuitable patients.
• Inadequate patient onboarding workflows permitted contraindicated patients to receive Byte treatments.
• The company was aware of numerous patient injury reports linked to Byte products.
• Dentsply failed to adequately investigate or report these serious injuries to the FDA, as required by law.
• The positive statements made by Dentsply regarding its products and business prospects were misleading and lacked a solid foundation.

The situation escalated when Dentsply announced on October 24, 2024, that it would temporarily halt sales and marketing of its Byte Aligners and Impression Kits while reviewing regulatory compliance. This announcement was framed as a precaution, but it also included an expected charge of approximately $450-$550 million related to goodwill impairment.

On November 7, 2024, after market closure, Dentsply disclosed significant financial results for the third quarter, revealing a non-cash charge for goodwill impairment of $495 million. In a subsequent earnings call, CEO Simon D. Campion stated that the company was reviewing future strategic options for its Byte business.

Following these revelations, Dentsply's stock price plummeted over 28%, marking a substantial decline in shareholder value.

The lead plaintiff in such cases is typically the investor who has the largest financial stake in the case and meets specific legal requirements to represent the interests of the class. Anyone interested can apply to be the lead plaintiff or choose to remain a passive member of the class.

Faruqi & Faruqi encourages anyone with information regarding Dentsply's actions, including whistleblowers and former employees, to come forward and share relevant details.

For more information about this class action regarding DENTSPLY SIRONA, visit www.faruqilaw.com/XRAY or contact Faruqi & Faruqi partner Josh Wilson directly as mentioned above.

Stay informed about updates on LinkedIn, X (formerly Twitter), or Facebook.

Attorney Advertising. The law firm's identity is Faruqi & Faruqi, LLP, located online at www.faruqilaw.com. Past outcomes do not guarantee similar future results.

DENTSPLY, lawsuit, investors